UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549








FORM 10-Q/A


(Amendment No. 1)





(Mark One)


TQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the Quarterly Period Ended March 31, 2011


Or


£TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period fromto





Commission file number: 000 – 52077


MEDPRO SAFETY PRODUCTS, INC.


(Exact name of registrant as specified in its charter)


Nevada91-2015980(State or other jurisdiction ofincorporation or organization)(I.R.S. EmployerIdentification No.)145 Rose Street, Lexington, KY40507(Address of principal executive offices)(Zip Code)


(859) 225-5375


(Registrant’s telephone number, including area code)








Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.


Yes T No £


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes £ No £


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer £ Accelerated filer £


Non-accelerated filer £ Smaller reporting company T


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes £ No T


Indicate the number of shares outstanding of each of the issuer’s class of common stock, as of the latest practicable date, 12,984,216 shares of Common Stock were outstanding at May 11, 2011.








---







Explanatory Note





This Amendment is being filed to correct the certifications of the Chief Executive Officer and the Chief Financial Officer furnished as Exhibits 32.1and 32.2, respectively.





In addition a revised Exhibit 31.2 is being furnished to correct the Chief Financial Officer's title in the heading of the exhibit.








---







SIGNATURES





Pursuant to the requirements of the Securities Exchange Act if 1934, the Registrant had duly caused this amendment to be signed on its behalf by the undersigned thereunto duly authorized.





MEDPRO SAFETY PRODUCTS, INC.(Registrant)December 13, 2011By:/s/ W. Craig TurnerW. Craig TurnerChief Executive Officer, Chairman of the Board of Directors(Principal Executive Officer)
  December 13, 2011By:/s/ Marc T. RayMarc T. RayVice President Finance and Chief Financial Officer(Principal Financial and Accounting Officer)





3


---




INDEX TO EXHIBITS


The following exhibits are filed with this report.


Exhibit No.Description


31.2Certification of Chief Financial Officer pursuant to SEC Rule 13(a)-14(a)32.1Certification of Chief Executive Officer pursuant to Section 1350 of Chapter 63 of Title 18 of the U.S. Code32.2Certifications of Chief Financial Officer, pursuant to Section 1350 of Chapter 63 of Title 18 of the U.S. Code


_________________________














4